Argireline, CAS number 616204-22-9

Argireline (Acetyl Hexapeptide-3) is a groundbreaking peptide-based compound, specifically formulated to target and reduce the appearance of dynamic wrinkles and fine lines. As a potent anti-wrinkle agent, Argireline has garnered widespread acclaim for its ability to inhibit neurotransmitter release, thereby reducing muscle contractions and providing a non-invasive alternative to traditional botulinum toxin injections.

Argireline works by interfering with the SNARE protein complex, crucial for the release of acetylcholine, a neurotransmitter responsible for muscle contractions. By inhibiting this process, Argireline effectively minimizes muscle movement, leading to a significant reduction in the formation of wrinkles. This mechanism makes Argireline particularly effective in reducing dynamic wrinkles such as crow's feet, forehead lines, and glabellar lines.

Numerous clinical studies have demonstrated the efficacy of Argireline. One notable study found that participants using a 5% Argireline solution experienced an average reduction of 30% in wrinkle depth after 28 days of consistent use.

PS Chemical Consortium has established itself as a leader in the production of high-quality Argireline through its advanced and innovative manufacturing processes. Our fully enclosed 100,000-level production workshop ensures the highest standards of cleanliness and precision, essential for producing consistent and effective skincare ingredients.

Our production process involves a meticulously optimized solid phase synthesis method, which includes resin swelling, amino resin preparation, peptide resin synthesis, and purification. This process not only ensures the high purity and potency of Argireline but also allows for efficient large-scale production. By leveraging our state-of-the-art facilities and expertise, we can produce Argireline at a kilogram level, significantly reducing costs and production time without compromising quality.